*Answering The Misinformed
There seems to be some confusion regarding an annual report submitted by new CEO Mark Miller on 3/9/2018.
This filing was an annual report for 2017 and clearly states period ending 12/31/2017. This annual report should
have been submitted by the previous management before their departure in January 2018. Any references within
that filing to warehouses or offices in Alabama or Florida reflect the previous management's claimed operations
for the year 2017. The new CEO met his fiduciary duty to shareholders by making sure the annual report for 2017
was submitted in order to bring MedX to current status. None of the information submitted in that filing is relevant
to the current operations of MedX as of 2018 and only pertains to the 2017 annual operations as depicted below.